Aptevo Raises $4.5M in Warrant Inducement and PIPE, Adding Significant Dilution
APVO is trading near its 52-week low of $3.35 (0.6% above the low).
Summary
Aptevo Therapeutics raised $4.5 million through a warrant inducement and PIPE, issuing millions of new warrants and shares at $4.03 per share, significantly diluting existing holders.
Key Events · Financing and Capital Events · APVO
-
Warrant Inducement and PIPE Closed
Aptevo closed a $4.5 million financing on August 13, 2026, consisting of a warrant inducement exercise of 254,922 shares at $4.03 and a private placement of up to 861,708 shares at $4.03.
-
Massive Warrant Issuance
The company issued 1,274,610 inducement warrants and 4,308,540 common warrants, all with an exercise price of $4.03, creating potential dilution of over 5.5 million shares.
-
Dilution Impact
With only 1,555,293 shares outstanding before the deal, the new shares and warrants could increase the share count by over 350% if fully exercised.
-
Use of Proceeds
Net proceeds will be used for working capital and general corporate purposes, extending the company's cash runway amid a going concern warning.
Analysis · APVO · Life Sciences
Aptevo Therapeutics closed a $4.5 million financing package on August 13, 2026, combining a warrant inducement exercise with a private placement. The deal includes the exercise of 254,922 existing warrants at a reduced price of $4.03, issuance of 1,274,610 inducement warrants, sale of up to 861,708 shares at $4.03, and issuance of 4,308,540 common warrants. The exercise price of $4.03 is above the current stock price of $3.37, but the massive warrant overhang—over 5.5 million shares underlying new warrants—represents substantial potential dilution for a company with only 1.55 million shares outstanding. The company is trading near its 52-week low and has a going concern warning, making this financing a critical survival move but one that heavily dilutes existing shareholders.
How filings like this one have moved
In the 30 days to Oct 17, 2026, 37.1% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.75%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, APVO was trading at $3.37 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.2M. The 52-week trading range was $3.35 to $48.78. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.